Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach
Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Apr 8, 2021
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Outcomes after weight loss surgery are quite variable with some patients regaining a significant amount of weight in the postoperative period. Increasing evidence suggests gastric bypass leads to weight loss and improvement in associated metabolic illness through mechanisms other than just restriction and malabsorption and may include circulating bile acids, gut hormones, genetic/epigenetic variability, changes in gut microbiota as well as other mechanisms. Whether modifications to bypassed intestine length may improve outcomes after gastric bypass has not been adequately studied with incon...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age greater than 18
- • 2. Body mass index of 40-60 kg/m2
- • 3. Meet insurance criteria, as set forth by the patient's insurance policy, to qualify for coverage for weight loss surgery
- • 4. Planned laparoscopic Roux-en-Y gastric bypass
- • 5. Willingness to have blood collected before and after surgical procedure at defined points and collect and mail stool sample before operation and at defined post-operative time points.
- Exclusion Criteria:
- • 1. Age less than 18
- • 2. Patient fails to fulfill insurance mandated criteria
- • 3. Unwilling to be randomized to variable length to gastric bypass or unwilling to have blood collected or personally collect and mail in stool sample
- • 4. Unwilling to follow-up at required postoperative visits
About University Of Missouri Columbia
The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Patients applied
Trial Officials
Andrew Wheeler, MD
Principal Investigator
University of Missouri-Columbia, Department of Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials